This is exemplified in Senolt et al.,23 where increases in matrix metalloproteinase 1, 2 and 9 protein and gene expression levels were seen in response to S100A4 oligomer treatment of synovial fibroblasts derived from patients with rheumatoid arthritis. This evidence concerns the gene MMP1 and rheumatoid arthritis.